Related references
Note: Only part of the references are listed.Merits and pitfalls of mifepristone in Cushing's syndrome
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Regulation of Aldosterone Secretion by Several Aberrant Receptors Including for Glucose-Dependent Insulinotropic Peptide in a Patient with an Aldosteronoma
Antoine Lampron et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas
Christiaan de Bruin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Treatment of Pituitary-Dependent Cushing's Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial
M. Boscaro et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
F. Castinetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Octreotide and the novel multireceptor ligand somatostatin receptor agonist pasireotide (SOM230) block the adrenalectomy-induced increase in mitotic activity in male rat anterior pituitary
L. A. Nolan et al.
ENDOCRINOLOGY (2007)
The PPAR-gamma activator rosiglitazone fails to lower plasma ACTH levels in patients with Nelson's syndrome
KR Mullan et al.
CLINICAL ENDOCRINOLOGY (2006)
Long term control of hypercortisolism with fluconazole:: case report and in vitro studies
M Riedl et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Effect of protracted treatment with rosiglitazone, a PPARγ agonist, in patients with Cushing's disease
FP Giraldi et al.
CLINICAL ENDOCRINOLOGY (2006)
Cabergoline plus lanreotide for ectopic Cushing's syndrome
R Pivonello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease
D Suri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease
JE Greening et al.
HORMONE RESEARCH (2005)
Effects of chronic administration of PPAR-γ ligand rosiglitazone in Cushing's disease
B Ambrosi et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma
T Miyoshi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2004)
Nelson's syndrome: Complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment
LA Casulari et al.
HORMONE RESEARCH (2004)
Ectopic ACTH-producing tumors of the chest and octreotide scintigraphy
PL Filosso et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2002)